Jeetinder Singh Mahal - 17 Mar 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Chief Operating Officer, Chief Financial Officer and Corporate Secretary
Signature: /s/ Jeet Mahal
Issuer symbol: JSPR
Transactions as of: 17 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 20 Mar 2023, 18:00:57 UTC
Previous filing: 13 Oct 2022
Next filing: 14 Apr 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JSPR	Stock Option (right to buy)	Award	$0	+350,000		$0.000000	350,000	17 Mar 2023	Voting Common Stock	350,000	$1.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on March 3, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Remarks:

Chief Operating Officer, Chief Financial Officer and Corporate Secretary